BAX

Baxter International Inc.

Healthcare
18.68 +0.28 +1.52% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 9.65B
EV —
Shares Out 516.47M
Revenue (ttm) 11.32B
Net Income -1.10B
Beta —
P/E -8.76
Forward P/E —
EPS (ttm) $-2.15
P/S 0.85
P/B 1.59
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA -5.53%
ROE -16.47%
ROIC -8.15%
Gross Margin 30.11%
Oper. Margin -2.65%
Profit Margin -9.7%
Debt/Eq 0.18
LT Debt/Eq —
Quick Ratio —
Current Ratio 1.85
Book/sh 11.73
Cash/sh 3.92
Div Yield 1.93%
Div TTM $0.36
Payout Ratio —
SMA20 2.65%
SMA50 5.58%
SMA200 -6.34%
Volume 4,758,347
Avg Volume 8.85M
Rel Volume —
Perf Week -2.96%
Perf Month 12.39%
Perf Quarter -1.84%
Perf Half Y 1.08%
Perf YTD -2.25%
Perf Year -37.67%
Perf 3Y -54.80%
Perf 5Y -77.29%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.0100
TTM Yield 1.93%
TTM Amount $0.36
Payout Ratio —
3-Yr Growth (CAGR) -23.25%
5-Yr Growth (CAGR) -11.45%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 2026-05-28 $0.0100
Q4 2025 2026-02-26 $0.0100
Q3 2025 ~2025-09-30 $0.1700
Q2 2025 ~2025-06-30 $0.1700
Q1 2025 ~2025-03-31 $0.1700
Q4 2024 ~2024-12-30 $0.1700
Q3 2024 ~2024-09-30 $0.2900
Q2 2024 ~2024-06-30 $0.2900
Q1 2024 ~2024-03-31 $0.2900
Q4 2023 ~2023-12-30 $0.2900
Q3 2023 ~2023-09-30 $0.2900
Q2 2023 ~2023-06-30 $0.2900

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Baxter International Inc. is a healthcare company that develops, manufactures and distributes essential medical products and therapies. The company operates through three reportable segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. The Medical Products & Therapies segment focuses on intravenous (IV) therapies and infusion systems serving critically ill patients and others in need of essential care. The Healthcare Systems & Technologies segment encompasses care coordination and clinical decision support solutions, connectivity technologies, and patient monitoring systems. The Pharmaceuticals segment offers intravenous medications, injectable drugs and other pharmaceutical therapies. The company's portfolio serves more than 350 million patients worldwide across more than 100 countries through a broad range of products, including IV solutions, infusion systems, premixed injectable drugs, and healthcare information technology platforms. Baxter maintains manufacturing facilities globally and supports hospitals, healthcare providers, and other institutions in delivering care.

Name
Baxter International Inc.
Industry
Medical Devices
CEO
Andrew P. Hider · President and Chief Executive Officer
Employees
38,000 as of 2025-12-31
IPO Date
2016-03-07
Phone
(224) 948-2000
Address
One Baxter Parkway, Deerfield, IL 60015
Website
www.baxter.com

Key Executives

Name Title FY Pay
Andrew P. Hider President and Chief Executive Officer $6.6M
Joel Grade Chief Financial Officer $2.9M
Heather Knight Chief Marketing and Chief Digital Officer $2.2M
David Rosenbloom Chief Supply Chain Officer $2.2M
Brent Shafer Non-Executive Chair of the Board —

Latest News